BMY: Bristol-Myers Squibb Co. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 129,946.29
Enterprise Value ($M) 133,164.82
Book Value ($M) 15,218.00
Book Value / Share 9.30
Price / Book 8.86
NCAV ($M) -2,424.00
NCAV / Share -1.48
Price / NCAV -55.60

Profitability (mra)
Return on Invested Capital (ROIC) 0.22
Return on Assets (ROA) 0.15
Return on Equity (ROE) 0.42

Liquidity (mrq)
Quick Ratio 1.79
Current Ratio 1.93

Balance Sheet (mrq) ($M)
Current Assets 17,093.00
Assets 34,834.00
Liabilities 19,517.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 22,561.00
Operating Income n/a
Net Income 4,947.00
Earnings Per Share Diluted 3.01
Earnings Per Share Basic 3.01

Cash Flow Statement (mra) ($M)
Cash From Operations 5,940.00
Cash from Investing -874.00
Cash from Financing -874.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-12 13G/A Vanguard Group Inc 8.32 47.96
2020-02-05 13G/A BlackRock Inc. 7.30 48.26
2020-01-28 13G/A Wellington Management Group LLP 3.57 -31.10
2015-02-13 13G/A Capital World Investors 4.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-05-07 10-Q March 31, 2020
2020-02-24 10-K December 31, 2019
2019-10-31 10-Q BMY / Bristol-Myers Squibb Co. 10-Q – Quarterly Report – 10-Q
2019-07-25 10-Q BMY / Bristol-Myers Squibb Co. 10-Q – Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-07-10 619,020 8,770,000 7.06
2020-07-09 1,052,235 12,780,300 8.23
2020-07-08 550,916 10,507,000 5.24
2020-07-07 898,672 12,767,100 7.04
2020-07-06 646,565 8,810,700 7.34

(click for more detail)

(click for list of largest short owners)

Similar Companies
AGN – Allergan plc ALR – Alere Inc.
BHS – Bausch Health Companies BXLT – Baxalta Incorporated
CBM – Cambrex Corp.


Financial data and stock pages provided by
Fintel.io